Admission to the General Hospital of Ciudad Juárez, Chihuahua, of a patient with COVID-19. Photo from .
Hugo López-Gatell recalled that the SSa warned that in October all the countries of the northern hemisphere would have a rebound in COVID-19, which will last until 2021
The Undersecretary of Prevention and Health Promotion, Hugo Lopez-Gatell, warned that the rebound in COVID-19 infections through which Mexico passes will last until March 2021.
I participated in the Forum of Experiences and Challenges of Addressing # COVID19 in Mexico and in Latin American and Caribbean countries, a space in which I exposed the actions we carry out to control the epidemic, as well as the challenges we face . pic.twitter.com/MUJh3q259s
– Hugo López-Gatell Ramírez (@HLGatell) November 20, 2020
The statement was made at the Forum of experiences and challenges in dealing with COVID-19 in Mexico and in countries of Latin America and the Caribbean, organized by Senator Américo Villareal and with the participation of the Pan American Health Organization (PAHO).
The federal official recalled that since March the Ministry of Health said that in October all the countries of the northern hemisphere would have a rebound, regardless of the epidemic control they had due to the cold season.
It is predictable that between now and at least until March 2021 we will have a new epidemic cycle in which our fundamental objective will continue to be to reduce the most virulent impact that this virus can have, “he said.
López-Gatell Ramírez stated that the Federal government will continue to work on the timely detection of cases, monitoring of oxygen saturation and the early referral of patients to specialized care.
He added that the challenges that persist are the extreme politicization of the pandemic and the “opportunistic use of information to profit politically from the human tragedy”, which according to the undersecretary, has been detonated by reaching more than 100,000 deaths from COVID-19.
He also warned about the infodemic which has led health professionals to assume that certain medicines are effective before coronavirus when there is no scientific and clinical evidence in this regard.
With information from López-Dóriga Digital